Annual NEALS Meeting 2024

October 21-24, 2024
Boston, MA

The Annual NEALS Meeting brings together researchers, clinicians, industry leaders, and individuals with lived ALS experience to discuss the latest advancements in ALS research and treatment. With a focus on member initiatives and potential new therapies, the meeting prepares attendees for upcoming clinical trials and fosters collaboration among the ALS community. The NEALS meeting agenda includes site management and outcome measures training sessions, informational sessions on the National ALS Registry, and meetings on various impactful studies:

• Pridopidine Second Expanded Access Protocol (EAP 2)
• RAPA-501-ALS Expanded Access Clinical Trial (EAP)
• REFINE-ALS Study
• HEALEY Platform Trial
• FUSION Clinical Trial in FUS-ALS
• ALL ALS Consortium
• CARDINALS Study

For twenty years PRC Clinical has actively guided ALS drug and biologic developers through the unique challenges facing ALS clinical trials. As an advocate for the ALS community and proud partner to several relevant industry events, organizations, and drug developers, PRC is determined to help advance ALS research and bring valuable therapies to patients.

View the Conference Website